Clinical Trial Update: Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study in healthy subjects evaluated the impact of activated charcoal and dosing time on LY2624803; results were posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• LY2624803 (LY2624803)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Insomnia | Phase 1 | Status: COMPLETED | Results posted: 2011-12-22